Search research articles
Contact Us
Filters
Showing results (281-290 of 294) with videos related to
Page
of 30
Sort By:
Stem Cell Research & Therapy
|
September 28, 2024
Human uncultured adipose-derived stromal vascular fraction shows therapeutic potential against osteoarthritis in immunodeficient rats via direct effects of transplanted M2 macrophages
Yuma Onoi, Tomoyuki Matsumoto, Kensuke Anjiki, et al.
Oncology Reports
|
December 20, 2024
<i>SPRR1A</i> is a potential therapeutic target for osteosarcoma: <i>in vitro</i> and <i>in vivo</i> evaluations using generated artificial osteosarcoma cancer stem cell‑like cells
Tomohiro Miyamoto, Naomasa Fukase, Teruya Kawamoto, et al.
Frontiers in Neurology
|
January 9, 2019
Distinct Incidence of Takotsubo Syndrome Between Amyotrophic Lateral Sclerosis and Synucleinopathies: A Cohort Study
Yuishin Izumi, Ryosuke Miyamoto, Koji Fujita, et al.
International Orthopaedics
|
March 25, 2018
Quality of life of patients with osteonecrosis of the femoral head: a multicentre study
Yuko Uesugi, Takashi Sakai, Taisuke Seki, et al.
The Journal of Experimental Medicine
|
September 22, 2010
Lnk-dependent axis of SCF-cKit signal for osteogenesis in bone fracture healing
Tomoyuki Matsumoto, Masaaki Ii, Hiromi Nishimura, et al.
RMD Open
|
August 19, 2023
Drug retention of biologics and Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort study
Kosuke Ebina, Yuki Etani, Yuichi Maeda, et al.
Rheumatology (Oxford, England)
|
May 9, 2024
Predictive factors and treatment outcomes associated with difficult-to-treat rheumatoid arthritis conditions: the ANSWER cohort study
Ryu Watanabe, Kosuke Ebina, Takaho Gon, et al.
Modern Rheumatology
|
March 19, 2025
Distinct impact of RF and ACPA titer on the effectiveness and persistency of biologics and JAK inhibitors: The ANSWER cohort study
Yuki Etani, Yasutaka Okita, Yuichi Maeda, et al.
International Journal of Rheumatic Diseases
|
March 5, 2024
Association of large joint involvement at the start of biological disease-modifying antirheumatic drugs and Janus kinase inhibitors with disease activity and drug retention in patients with rheumatoid arthritis: The ANSWER cohort study
Iku Shirasugi, Akira Onishi, Keisuke Nishimura, et al.
Rheumatology (Oxford, England)
|
October 4, 2023
Trends of disease activity in Japanese patients over 75 years with rheumatoid arthritis from 2014 to 2021: the ANSWER cohort study
Hirotaka Yamada, Sadao Jinno, Toshihisa Maeda, et al.
Page
of 30
Search research articles
Search
Showing results (281-290 of 294) with videos related to
Sort By:
Page
of 30
Stem Cell Research & Therapy
|
September 28, 2024
Human uncultured adipose-derived stromal vascular fraction shows therapeutic potential against osteoarthritis in immunodeficient rats via direct effects of transplanted M2 macrophages
Yuma Onoi, Tomoyuki Matsumoto, Kensuke Anjiki, et al.
Oncology Reports
|
December 20, 2024
<i>SPRR1A</i> is a potential therapeutic target for osteosarcoma: <i>in vitro</i> and <i>in vivo</i> evaluations using generated artificial osteosarcoma cancer stem cell‑like cells
Tomohiro Miyamoto, Naomasa Fukase, Teruya Kawamoto, et al.
Frontiers in Neurology
|
January 9, 2019
Distinct Incidence of Takotsubo Syndrome Between Amyotrophic Lateral Sclerosis and Synucleinopathies: A Cohort Study
Yuishin Izumi, Ryosuke Miyamoto, Koji Fujita, et al.
International Orthopaedics
|
March 25, 2018
Quality of life of patients with osteonecrosis of the femoral head: a multicentre study
Yuko Uesugi, Takashi Sakai, Taisuke Seki, et al.
The Journal of Experimental Medicine
|
September 22, 2010
Lnk-dependent axis of SCF-cKit signal for osteogenesis in bone fracture healing
Tomoyuki Matsumoto, Masaaki Ii, Hiromi Nishimura, et al.
RMD Open
|
August 19, 2023
Drug retention of biologics and Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort study
Kosuke Ebina, Yuki Etani, Yuichi Maeda, et al.
Rheumatology (Oxford, England)
|
May 9, 2024
Predictive factors and treatment outcomes associated with difficult-to-treat rheumatoid arthritis conditions: the ANSWER cohort study
Ryu Watanabe, Kosuke Ebina, Takaho Gon, et al.
Modern Rheumatology
|
March 19, 2025
Distinct impact of RF and ACPA titer on the effectiveness and persistency of biologics and JAK inhibitors: The ANSWER cohort study
Yuki Etani, Yasutaka Okita, Yuichi Maeda, et al.
International Journal of Rheumatic Diseases
|
March 5, 2024
Association of large joint involvement at the start of biological disease-modifying antirheumatic drugs and Janus kinase inhibitors with disease activity and drug retention in patients with rheumatoid arthritis: The ANSWER cohort study
Iku Shirasugi, Akira Onishi, Keisuke Nishimura, et al.
Rheumatology (Oxford, England)
|
October 4, 2023
Trends of disease activity in Japanese patients over 75 years with rheumatoid arthritis from 2014 to 2021: the ANSWER cohort study
Hirotaka Yamada, Sadao Jinno, Toshihisa Maeda, et al.
Page
of 30